These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 207403)

  • 1. Efficacy of laboratory tests for the detection of enterotoxigenic Clostridium perfringens.
    Niilo L
    Can J Microbiol; 1978 May; 24(5):633-5. PubMed ID: 207403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of enterotoxigenic Clostridium perfringens type A in mixed cultures.
    Niilo L
    Can J Comp Med; 1979 Jan; 43(1):98-101. PubMed ID: 218711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro production of Clostridium perfringens enterotoxin and its detection by reversed passive hemagglutination.
    Uemura T; Sakaguchi G; Riemann HP
    Appl Microbiol; 1973 Sep; 26(3):381-5. PubMed ID: 4356461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Clostridium botulinum by strains of Clostridium perfringens isolated from soil.
    Smith LD
    Appl Microbiol; 1975 Aug; 30(2):319-23. PubMed ID: 169734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction between Clostridium botulinum type A strains associated with food-borne botulism and those with infant botulism in Japan in intraintestinal toxin production in infant mice and some other properties.
    Tabita K; Sakaguchi S; Kozaki S; Sakaguchi G
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):251-6. PubMed ID: 1905658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay methods for Clostridium perfringens type A enterotoxin.
    Genigeorgis C; Sakaguchi G; Riemann H
    Appl Microbiol; 1973 Jul; 26(1):111-5. PubMed ID: 4353692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
    Sonnenschein B
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of food-poisoning (enterotoxigenic) Clostridium perfringens type A in blood and fish meal.
    Chakrabarty AK; Boro BR
    Zentralbl Bakteriol Mikrobiol Hyg B; 1981 Jan; 172(4-5):427-33. PubMed ID: 6261484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interconversion of bacterial agents causing botulism and gas gangrene.
    Nutr Rev; 1975 Apr; 33(4):120-2. PubMed ID: 165441
    [No Abstract]   [Full Text] [Related]  

  • 10. A survey of Clostridium perfringens enterotoxin antibody in human and animal sera in western Canada.
    Niilo L; Bainborough AR
    Can J Microbiol; 1980 Sep; 26(9):1162-4. PubMed ID: 6257364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse phase passive haemagglutination and single radial immunodiffusion to detect epsilon antigen of Clostridium perfringens type D.
    Beh KJ; Buttery SH
    Aust Vet J; 1978 Nov; 54(11):541-4. PubMed ID: 223537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symposium on microbial changes in foods. Factors affecting the production of bacterial food poisoning toxins.
    Baird-Parker AC
    J Appl Bacteriol; 1971 Mar; 34(1):181-97. PubMed ID: 4327570
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative evidence of intestinal colonization by Clostridium botulinum in four cases of infant botulism.
    Wilcke BW; Midura TF; Arnon SS
    J Infect Dis; 1980 Apr; 141(4):419-23. PubMed ID: 6989924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterotoxigenic Clostridium perfringens type A isolated from intestinal contents of cattle, sheep and chickens.
    Niilo L
    Can J Comp Med; 1978 Jul; 42(3):357-63. PubMed ID: 210914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Clostridium botulinum strains associated with an infant botulism case in the United Kingdom.
    Johnson EA; Tepp WH; Bradshaw M; Gilbert RJ; Cook PE; McIntosh ED
    J Clin Microbiol; 2005 Jun; 43(6):2602-7. PubMed ID: 15956371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent-antibody reagents for the identification of Clostridium botulinum.
    Glasby C; Hatheway CL
    J Clin Microbiol; 1983 Dec; 18(6):1378-83. PubMed ID: 6361053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.
    Barash JR; Arnon SS
    J Infect Dis; 2014 Jan; 209(2):183-91. PubMed ID: 24106296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the effect of ionizing radiation on resistance, germination, and toxin synthesis of Clostridium botulinum spores, types A, B, and E. COO-1095-3.
    Graikoski JT; Kempe LL
    COO Rep; 1966 Jan; ():1-100. PubMed ID: 4312998
    [No Abstract]   [Full Text] [Related]  

  • 19. Botulinum neurotoxins: more and more diverse and fascinating toxic proteins.
    Popoff MR
    J Infect Dis; 2014 Jan; 209(2):168-9. PubMed ID: 24106294
    [No Abstract]   [Full Text] [Related]  

  • 20. [MIXED DIETARY TOXINFECTION CAUSED BY CLOSTRIDIUM BOTULINUM AND CLOSTRIDIUM PERFRINGENS].
    CRISTEA I; BARA C; CERNI I; SECASIU V
    Microbiol Parazitol Epidemiol (Bucur); 1963; 8():49-54. PubMed ID: 14047907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.